logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Prostate-specific antigen as predictor of prostate cancer in black men and white men.

    Article - En anglais

    Background 

    The increasing incidence of prostate cancer creates complex issues in health care management and cost containment.

    There is a need to evaluate serial measurements of prostate-specific antigen (PSA) as a marker for long-term risk of clinically important prostate cancer (stages B through D).

    Purpose 

    We used a nested case-control design within a retrospective cohort study to evaluate serial PSA concentrations in relation to subsequent prostate cancer diagnoses.

    Results 

    Median serum PSA concentrations, specific for age and subsequent cancer status, were similar in blacks and whites.

    Concentrations in control subjects increased exponentially with age, with a doubling time of 24.9 years.

    Concentrations in men with stage A cancer were similar to those in control subjects.

    Until about 13 years before diagnosis, PSA in men with subsequent cancer stages B through D increased exponentially with age, with a doubling time similar to that of control subjects.

    Conclusions 

    These data suggest that 1) age-specific PSA concentrations are similar in black men and white men and 2) current PSA concentration, specific for age, outperforms changes in past concentrations in identifying the man who will develop stage B, C, or D cancer within 7 years, albeit at the cost of a slightly higher rate of false-positive results.

    This interpretation needs confirmation in other data containing many serial PSA measurements within a few years of diagnosis.

    Mots-clés Pascal : Tumeur maligne, Prostate, Marqueur tumoral, Facteur risque, Epidémiologie, Caucasoïde, Négroïde, Etats Unis, Amérique du Nord, Amérique, Homme, Prostate pathologie, Appareil urinaire pathologie, Appareil génital mâle pathologie, Antigène spécifique prostate

    Mots-clés Pascal anglais : Malignant tumor, Prostate, Tumoral marker, Risk factor, Epidemiology, Caucasoid, Negroid, United States, North America, America, Human, Prostate disease, Urinary system disease, Male genital diseases, Prostate specific antigen

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 95-0352382

    Code Inist : 002B14D02. Création : 01/03/1996.